Target intelligence / Profile preview

Fc gamma receptor and transporter (FcRn) (FcRn)

Target
FcRn
Molecular classification
Receptor
01

Overview

The Fc gamma receptor and transporter (FcRn) is a cell surface receptor that binds the Fc region of monomeric immunoglobulin G (IgG), playing a critical role in transferring passive humoral immunity from mother to fetus or neonate across the placenta or intestinal epithelium. In adults, FcRn resides primarily in endosomal compartments, where it exhibits pH-dependent binding: high affinity for IgG at acidic pH (<6.5) enables sorting and recycling of internalized IgG and serum albumin to the cell surface at neutral pH, thereby extending their half-lives and preventing lysosomal degradation. FcRn also facilitates the transcytosis of IgG across epithelial barriers, such as in the intestine, and co-expression with Fc gamma receptors in antigen-presenting cells like macrophages and dendritic cells enhances antigen uptake, intracellular trafficking of IgG-immune complexes, and MHC class II-mediated presentation. Its expression is upregulated by proinflammatory cytokine TNF-α and downregulated by anti-inflammatory IFN-γ, linking it to immune regulation. In disease contexts, FcRn at the blood-brain barrier regulates IgG movement into and out of the central nervous system, with implications for neurological disorders and immune surveillance; hepatic FcRn directs albumin recirculation, influencing hepatocyte toxicity sensitivity. Therapeutically, FcRn represents a target for modulating IgG levels in autoimmune and inflammatory conditions, though challenges include balancing immunity without compromising protein homeostasis.

Other names
neonatal Fc receptorneonatal fragment crystallizable receptor
02

Mechanism of action

pH-dependent binding to IgG Fc region in acidic endosomes for recycling to cell surface, avoiding lysosomal degradation; transport of IgG-immune complexes for antigen presentation

03

Biological functions

Transport of IgG across epithelial barriersregulation of IgG and albumin half-lifeantigen presentationpassive immunity transfer from mother to offspring
04

Disease associations

Inflammationneurological diseaseinfection
05

Safety considerations

Potential disruption of IgG and albumin homeostasis leading to immunodeficiency or toxicityupregulation by proinflammatory cytokines like TNF-α may exacerbate inflammation
06

Interacting drugs

FcRn inhibitors

Beyond the preview

Go deeper on Fc gamma receptor and transporter (FcRn) (FcRn).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fc gamma receptor and transporter (FcRn) (FcRn).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call